Professor Sir Andrew Pollard, director of the Oxford Vaccine Group, has said that the UK is "going to have to live with" COVID-19, BBC News reported on Wednesday.
Prof Pollard, speaking to the Commons Science and Technology Committee, was quoted as saying that "variants and their emergence" will "continue to happen".
He added: "But in the end, we're going to have to come back to focusing on the really important public health issue, which is the hospitalisation and the death. If transmission is disconnected by vaccine immunity from the severe disease, to a large extent, then we'll need to monitor new variants, perhaps, if we need to find new vaccines and so on - but we are going to have to live with it being in our communities and transmitting."
AstraZeneca launches online platform to expand patient access to medications
Sanofi increases Sanofi Ventures funding by USD625m to boost biotech and digital health investments
GC Biopharma submits IND application in South Korea for Phase 1 trial of COVID-19 vaccine candidate
AusperBio completes patient enrolment in two Phase II clinical trials of AHB-137
LakeShore Biopharma receives Nasdaq delisting determination letter
Valneva reports strong Phase 2 booster results for Lyme disease vaccine candidate VLA15
GC Biopharma files IND for Phase 3 trial of BARYCELA in Thailand